A Bapsi Chakravarthy - JoVE Visualize

Showing results (51-60 of 60) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 60 results.

Physics in Medicine and Biology|August 16, 2011

A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancerXia Li, E Brian Welch, Lori R Arlinghaus, et al.

JAMA Oncology|July 9, 2017

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.

European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2016

Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imagingJason M Williams, Lori R Arlinghaus, Sudheer D Rani, et al.

European Journal of Cancer (Oxford, England : 1990)|October 2, 2019

Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)Eleonor Rivin Del Campo, Oscar Matzinger, Karin Haustermans, et al.

Magnetic Resonance in Medicine|May 11, 2013

DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findingsXia Li, Lori R Arlinghaus, Gregory D Ayers, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.

Cancer|April 25, 2019

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010

Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiationJoshua A Bauer, A Bapsi Chakravarthy, Jennifer M Rosenbluth, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.

The Oncologist|December 20, 2019

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)A Bapsi Chakravarthy, Fengmin Zhao, Neal J Meropol, et al.

Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 60 results.

Physics in Medicine and Biology|August 16, 2011

A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancerXia Li, E Brian Welch, Lori R Arlinghaus, et al.

JAMA Oncology|July 9, 2017

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.

European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2016

Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imagingJason M Williams, Lori R Arlinghaus, Sudheer D Rani, et al.

European Journal of Cancer (Oxford, England : 1990)|October 2, 2019

Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)Eleonor Rivin Del Campo, Oscar Matzinger, Karin Haustermans, et al.

Magnetic Resonance in Medicine|May 11, 2013

DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findingsXia Li, Lori R Arlinghaus, Gregory D Ayers, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.

Cancer|April 25, 2019

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010

Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiationJoshua A Bauer, A Bapsi Chakravarthy, Jennifer M Rosenbluth, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.

The Oncologist|December 20, 2019

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)A Bapsi Chakravarthy, Fengmin Zhao, Neal J Meropol, et al.

Pageof 6